Company intelligence / Profile preview

Leman SKL Pharmaceuticals

Geneva / Petit-Lancy, Geneva, Switzerlandleman-skl.com ↗

Ownership: Private
Development stage: Commercial

Overview

Leman SKL develops and globally markets approved generic and established branded pharmaceuticals for hospital and outpatient care, with core strengths in dermatology and a broadened portfolio including antibiotics, oncology, and other therapeutic areas. All medicines are approved by Swissmedic and European regulators; recent Swiss authorization for import/distribution of injectable acetylsalicylic acid due to shortages.

Therapeutic areas: RheumatologyPsychiatryMen's HealthInfectious DiseasesGastroenterologyDermatologyCardiovascularOtherOncologyWomen's Health
Modalities: Small moleculeGeneric drugsBiologic
Industry: Biotech

Drug pipeline

1 asset

acetylsalicylic acid

Commercial

Indications: Injectable formulation

Beyond the preview

Go deeper on Leman SKL Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leman SKL Pharmaceuticals.

Explore the full profile